Home > Drug Search >
  • company_query: Aegera
  •   > 
Drug Filter
Category:
chemistry (14) biology (2)
Status:
Approved (2) Phase Ⅲ (4) Phase Ⅱ (7) Phase Ⅰ (3)
Clinical Stage:
Pending (1) Active (6) Discontinued (7)
Bio-Type:
Vaccine (1) Recombinant hormone (1)
Indication:
Acute liver damage caused by drug (1) Acute myeloid Leukemia (AML) (1) Asthma (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (2) Contrast agents (1) Cutaneous fungal infections (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) Hypertension (1) Malignancies (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (3) Prostate cancer (1) Small cell lung cancer (SCLC) (1) Colorectal cancer (1) Pneumocystis pneumonia (1) Methicillin-resistant staphylococcus aureus infections (1) B-cell lymphoma (1) Diabetes (1) Sickle cell disease (1) Ischemic stroke (1) Glioblastoma (1) Traumatic brain injury (1) Diffuse large B cell lymphoma (1) Renal failure (1) Myocardia ischemia (1) Congenital lactic acidosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top